Molecular perspectives for mu/delta opioid receptor heteromers as distinct, functional receptors

Cells

Volumn 3, Issue 1, 2014, Pages 152-179

  Ong, Edmund W ^a   Cahill, Catherine M ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Delta opioid receptor; G protein coupled receptor; Heteromer; Internalization; Mu opioid receptor; Oligomerization; Receptor signaling; Trafficking

Indexed keywords

CHAPERONE; DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

CRYSTALLOGRAPHY; FLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN QUATERNARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84906074966     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3010152     Document Type: Review

References (75)

1. Pasternak, G.W. Multiple opiate receptors: déjà vu all over again. Neuropharmacology 2004, 47 (Suppl. 1), 312-323.
2. Gris, P.; Gauthier, J.; Cheng, P.; Gibson, D.G.; Gris, D.; Laur, O.; Pierson, J.; Wentworth, S.; Nackley, A.G.; Maixner, W.; et al. A novel alternatively spliced isoform of the mu-opioid receptor: Functional antagonism. Mol. Pain 2010, 6, 33.
3. Costantino, C.M.; Gomes, I.; Stockton, S.D.; Lim, M.P.; Devi, L.A. Opioid receptor heteromers in analgesia. Expert Rev. Mol. Med. 2012, 14, e9.
4. Bouvier, M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2001, 2, 274-286.
5. George, S.R.; O'Dowd, B.F.; Lee, S.P. G-Protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 2002, 1, 808-820.
6. Lee, S. Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci. 2003, 74, 173-180.
7. Terrillon, S.; Bouvier, M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004, 5, 30-34.
8. Gurevich, V. V; Gurevich, E.V. How and why do GPCRs dimerize? Trends Pharmacol. Sci. 2008, 29, 234-240.
9. Vidi, P.; Chemel, B.R.; Hu, C.; Watts, V.J. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells. Mol. Pharmacol. 2008, 74, 544-551.
10. Jordan, B.A.; Devi, L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399, 697-700.
11. Gomes, I.; Jordan, B.A.; Gupta, A.; Trapaidze, N.; Nagy, V.; Devi, L.A. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J. Neurosci. 2000, 20, RC110.
12. George, S.R.; Fan, T.; Xie, Z.; Tse, R.; Tam, V.; Varghese, G.; O'Dowd, B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 2000, 275, 26128-26135.
13. Gomes, I.; Filipovska, J.; Jordan, B.A.; Devi, L.A. Oligomerization of opioid receptors. Methods 2002, 27, 358-365.
14. Wang, D.; Sun, X.; Bohn, L.M.; Sade, W. Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol. Pharmacol. 2005, 67, 2173-2184.
15. Fan, T.; Varghese, G.; Nguyen, T.; Tse, R.; O'Dowd, B.F.; George, S.R. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J. Biol. Chem. 2005, 280, 38478-38488.
16. Hasbi, A.; Nguyen, T.; Fan, T.; Cheng, R.; Rashid, A.; Alijaniaram, M.; Rasenick, M.M.; O'Dowd, B.F.; George, S.R. Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists. Biochemistry 2007, 46, 12997-13009.
17. Décaillot, F.M.; Rozenfeld, R.; Gupta, A.; Devi, L.A. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 16045-16050.
18. Stockton, S.D.; Devi, L.A. Functional relevance of u-6 opioid receptor heteromerization: A role in novel signaling and implications for the treatment of addiction disorders: From a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend. 2012, 121, 167-172.
19. Manglik, A.; Kruse, AC.; Kobilka, T.S.; Thian, F.S.; Mathiesen, J.M.; Sunahara, R.K.; Pardo, L.; Weis, W.I.; Kobilka, B.K.; Granier, S. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 2012, 485, 321-326.
20. Granier, S.; Manglik, A.; Kruse, AC.; Kobilka, T.S.; Thian, F.S.; Weis, W.I.; Kobilka, B.K. Structure of the 6-opioid receptor bound to naltrindole. Nature 2012, 485, 400-404.
21. Wu, H.; Wacker, D.; Mileni, M.; Katritch, V.; Han, GW.; Vardy, E.; Liu, W.; Thompson, A.A.; Huang, X.-P.; Carroll, F.I.; et al. Structure of the human K-opioid receptor in complex with JDTic. Nature 2012, 485, 327-332.
22. Thompson, A.A.; Liu, W.; Chun, E.; Katritch, V.; Wu, H.; Vardy, E.; Huang, X.-P.; Trapella, C.; Guerrini, R.; Calo, G.; et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 2012, 485, 395-399.
23. Filizola, M.; Devi, L.A. Structural biology: How opioid drugs bind to receptors. Nature 2012, 485, 314-317.
24. Filizola, M.; Devi, L.A. Grand opening of structure-guided design for novel opioids. Trends Pharmacol. Sci. 2013, 34, 6-12.
25. Filizola, M.; Olmea, O.; Weinstein, H. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Eng. 2002, 15, 881-885.
26. Liu, X.; Kai, M.; Jin, L.; Wang, R. Computational study of the heterodimerization between mu and delta receptors. J. Comput. Aided. Mol. Des. 2009, 23, 321-332.
27. He, S.-Q.; Zhang, Z.-N.; Guan, J.-S.; Liu, H.-R.; Zhao, B.; Wang, H.-B.; Li, Q.; Yang, H.; Luo, J.; Li, Z.-Y.; et al. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron 2011, 69, 120-131.
28. O'Dowd, B.F.; Ji, X.; O'Dowd, P.B.; Nguyen, T.; George, S.R. Disruption of the mu-delta opioid receptor heteromer. Biochem. Biophys. Res. Commun. 2012, 422, 556-560.
29. Cheng, P.Y.; Liu-Chen, L.Y.; Pickel, V.M. Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res. 1997, 778, 367-380.
30. Scherrer, G.; Imamachi, N.; Cao, Y.-Q.; Contet, C.; Mennicken, F.; O'Donnell, D.; Kieffer, B.L.; Basbaum, A.I. Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 2009, 137, 1148-1159.
31. Wang, H.-B.; Zhao, B.; Zhong, Y.-Q.; Li, K.-C.; Li, Z.-Y.; Wang, Q.; Lu, Y.-J.; Zhang, Z.-N.; He, S.-Q.; Zheng, H.-C.; et al. Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 13117-13122.
32. Chieng, B.; Christie, M.J. Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 2009, 57, 430-437.
33. Beaudry, H.; Dubois, D.; Gendron, L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J. Neurosci. 2011, 31, 13068-13077.
34. Massotte, D. Co-localization of mu and delta opioid receptors in the nervous system using double fluorescent knock-in mice. In Proceedings of the International Narcotics Research Conference, Cairns, Australia, July 2013; p. 8.
35. Wang, H.-B.; Guan, J.-S.; Bao, L.; Zhang, X. Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem. Res. 2008, 33, 2028-2034.
36. Scherrer, G.; Tryoen-Tóth, P.; Filliol, D.; Matifas, A.; Laustriat, D.; Cao, Y.Q.; Basbaum, A.I.; Dierich, A.; Vonesh, J.-L.; Gavériaux-Ruff, C.; et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 9691-9696.
37. Gupta, A.; Mulder, J.; Gomes, I.; Rozenfeld, R.; Bushlin, I.; Ong, E.; Lim, M.; Maillet, E.; Junek, M.; Cahill, C.M.; et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci. Signal. 2010, 3, 54.
38. Cahill, C.M.; Morinville, A.; Lee, M.C.; Vincent, J.P.; Collier, B.; Beaudet, A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J. Neurosci. 2001, 21, 7598-7607.
39. Gendron, L.; Lucido, A.L.; Mennicken, F.; O'Donnell, D.; Vincent, J.-P.; Stroh, T.; Beaudet, A. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J. Neurosci. 2006, 26, 953-962.
40. Morinville, A.; Cahill, C.M.; Esdaile, M.J.; Aibak, H.; Collier, B.; Kieffer, B.L.; Beaudet, A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: Evidence from mu-opioid receptor knock-out mice. J. Neurosci. 2003, 23, 4888-4898.
41. Morinville, A.; Cahill, C.M.; Kieffer, B.; Collier, B.; Beaudet, A. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 2004, 109, 266-273.
42. Law, P.-Y.; Erickson-Herbrandson, L.J.; Zha, Q.Q.; Solberg, J.; Chu, J.; Sarre, A.; Loh, H.H. Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J. Biol. Chem. 2005, 280, 11152-11564.
43. Petaja-Repo, U.E.; Hogue, M.; Laperriere, A.; Bhalla, S.; Walker, P.; Bouvier, M. Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J. Biol. Chem. 2001, 276, 4416-4423.
44. Cahill, C.M.; McClellan, K.A.; Morinville, A.; Hoffert, C.; Hubatsch, D.; O'Donnell, D.; Beaudet, A. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J. Comp. Neurol. 2001, 440, 65-84.
45. Saito, H.; Kubota, M.; Roberts, R.W.; Chi, Q.; Matsunami, H. RTP family members induce functional expression of mammalian odorant receptors. Cell 2004, 119, 679-691.
46. Petäjä-Repo, U.E.; Hogue, M.; Bhalla, S.; Laperrière, A.; Morello, J.-P.; Bouvier, M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J. 2002, 21, 1628-1637.
47. Petäjä-Repo, U.E.; Hogue, M.; Leskelä, T.T.; Markkanen, P.M. H.; Tuusa, J.T.; Bouvier, M. Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor. J. Biol. Chem. 2006, 281, 15780-15789.
48. Walwyn, W.; John, S.; Maga, M.; Evans, C.J.; Hales, T.G. Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol. Pharmacol. 2009, 76, 134-143.
49. Portoghese, P.S.; Lunzer, M.M. Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. Eur. J. Pharmacol. 2003, 467, 233-234.
50. Ansonoff, M.A.; Portoghese, P.S.; Pintar, J.E. Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands. Psychopharmacology 2010, 210, 161-168.
51. Van Rijn, R.M.; Harvey, J.H.; Brissett, D.I.; DeFriel, J.N.; Whistler, J.L. Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling. J. Pharmacol. Exp. Ther. 2013, 344, 179-188.
52. Yekkirala, A.S.; Kalyuzhny, A.E.; Portoghese, P.S. Standard opioid agonists activate heteromeric opioid receptors: Evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists. ACS Chem. Neurosci. 2010, 1, 146-154.
53. Waldhoer, M.; Fong, J.; Jones, R.M.; Lunzer, M.M.; Sharma, S.K.; Kostenis, E.; Portoghese, P.S.; Whistler, J.L. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 9050-9055.
54. Metcalf, M.D.; Yekkirala, A.S.; Powers, M.D.; Kitto, K.F.; Fairbanks, C.A.; Wilcox, G.L.; Portoghese, P.S. The δ Opioid Receptor Agonist SNC80 Selectively Activates Heteromeric μ-δ Opioid Receptors. ACS Chem. Neurosci. 2012, 3, 505-509.
55. Milan-Lobo, L.; Whistler, J.L. Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking. J. Pharmacol. Exp. Ther. 2011, 337, 868-875.
56. Gomes, I.; Gupta, A.; Filipovska, J.; Szeto, H.H.; Pintar, J.E.; Devi, L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5135-5139.
57. Szentirmay, A.K.; Király, K.P.; Lenkey, N.; Lackó, E.; Al-Khrasani, M.; Friedmann, T.; Timár, J.; Gyarmati, S.; Tóth, G.; Fürst, S.; et al. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Brain Res. Bull. 2013, 90, 66-71.
58. Yekkirala, A.S.; Banks, M.L.; Lunzer, M.M.; Negus, S.S.; Rice, K.C.; Portoghese, P.S. Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys. ACS Chem. Neurosci. 2012, 3, 720-727.
59. Daniels, D.J.; Lenard, N.R.; Etienne, C.L.; Law, P.-Y.; Roerig, S.C.; Portoghese, P.S. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 19208-19213.
60. Gomes, I.; Fujita, W.; Gupta, A.; Saldanha, A.S.; Negri, A.; Pinello, C.E.; Roberts, E.; Filizola, M.; Hodder, P.; Devi, L.A. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 12072-12077.
61. Rozenfeld, R.; Devi, L.A. Receptor heterodimerization leads to a switch in signaling: Beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J. 2007, 21, 2455-2465.
62. Bhushan, R.G.; Sharma, S.K.; Xie, Z.; Daniels, D.J.; Portoghese, P.S. A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J. Med. Chem. 2004, 47, 2969-2972.
63. Daniels, D.J.; Kulkarni, A.; Xie, Z.; Bhushan, R.G.; Portoghese, P.S. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. J. Med. Chem. 2005, 48, 1713-1716.
64. Lenard, N.R.; Daniels, D.J.; Portoghese, P.S.; Roerig, S.C. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Eur. J. Pharmacol. 2007, 566, 75-82.
65. Groer, C.E.; Tidgewell, K.; Moyer, R.A.; Harding, W.W.; Rothman, R.B.; Prisinzano, T.E.; Bohn, L.M. An opioid agonist that does not induce micro-opioid receptor--arrestin interactions or receptor internalization. Mol. Pharmacol. 2007, 71, 549-557.
66. He, L.; Kim, J.A.; Whistler, J.L. Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J. 2009, 23, 4327-4234.
67. Kim, J.A.; Bartlett, S.; He, L.; Nielsen, C.K.; Chang, A.M.; Kharazia, V.; Waldhoer, M.; Ou, C.J.; Taylor, S.; Ferwerda, M.; et al. Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr. Biol. 2008, 18, 129-135.
68. Pradhan, A.A. A.; Walwyn, W.; Nozaki, C.; Filliol, D.; Erbs, E.; Matifas, A.; Evans, C.; Kieffer, B.L. Ligand-directed trafficking of the δ-opioid receptor in vivo: Two paths toward analgesic tolerance. J. Neurosci. 2010, 30, 16459-16468.
69. Cahill, C.M.; Holdridge, S.V; Morinville, A. Trafficking of delta-opioid receptors and other G-protein-coupled receptors: Implications for pain and analgesia. Trends Pharmacol. Sci. 2007, 28, 23-31.
70. Law, P.Y.; Loh, H.H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther. 1999, 289, 607-624.
71. Martini, L.; Whistler, J.L. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr. Opin. Neurobiol. 2007, 17, 556-564.
72. Zuo, Z. The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth. Analg. 2005, 101, 728-734, table of contents.
73. Drake, M.T.; Shenoy, S.K.; Lefkowitz, R.J. Trafficking of G protein-coupled receptors. Circ. Res. 2006, 99, 570-582.
74. Tanowitz, M.; Von Zastrow, M. Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J. Biol. Chem. 2002, 277, 50219-50222.
75. Whistler, J.L.; Enquist, J.; Marley, A.; Fong, J.; Gladher, F.; Tsuruda, P.; Murray, S.R.; Von Zastrow, M. Modulation of postendocytic sorting of G protein-coupled receptors. Science 2002, 297, 615-620.